About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Japanese CTO PCI Expert Registry | Clinical Trials | Clareo Health

Back to clinical trial search

RECRUITINGNCT01889459

Japanese CTO PCI Expert Registry

The purpose of this study is to establish a consensus of treatment strategy of percutaneous coronary intervention (PCI) for chronic total occlusion (CTO) through patient registry of PCI for CTO perfor...

Lead sponsor: Kurashiki Central Hospital•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Keiko Oka

CONTACT

81-86-422-0210 cto.e.registry@gmail.com

Harumi Katoh, MD, PhD

CONTACT

81-86-422-0210 hk10731@kchnet.or.jp

Sponsors

Lead Sponsor

Kurashiki Central Hospital

Collaborators

Japanese CTO PCI Expert Registry investigators

Age

20 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Patients eligible for PCI
•Patients who underwent PCI for CTO lesions that contain the following:
•1. Thrombolysis in myocardial infarction trial (TIMI) 0
•2. The occlusive period more than 3 months or unknown
•3. The main coronary arteries (segment 1-3, 5-8, 11, 13), branches that have large perfusion area (segment 4PL, 9/10, 12) and graft

Exclusion Criteria

•Patients ineligible for PCI judged in clinical practice

Related studies

ISCHEMIA-CTO Trial - Revascularisation or Optimal Medical Therapy of CTO

NCT03563417 · Ischemic Heart Disease, Chronic Total Occlusion of Coronary Artery

Coronary Crossing System in Patients With Coronary Chronic Total Occlusions

NCT05813704 · Chronic Total Occlusion of Coronary Artery

To Evaluate Whether IVUS-guided Drug-eluting Stent (DES) Implantation Leads to Better Clinical Outcomes Compared to Conventional Angiography in the Treatment of Chronic Complete Occlusion (CTO) Disease.

NCT04944615 · Chronic Total Occlusion of Coronary Artery

Predictors and Long-term Incidence of In-stent Restenosis After Chronic Total Occlusion Percutaneous Coronary Intervention

NCT07473596 · Coronary Artery Disease (CAD), Chronic Total Occlusion of Coronary Artery, and more

Sapphire 3 CTO Study

NCT06358508 · Coronary Artery Disease, Coronary Disease, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: July 2, 2013Terms

Trial snapshot

StatusRECRUITING

Phase—

Enrollment19,000

Start dateJul 2013

Last updatedJul 2, 2013

Condition

Chronic Total Occlusion of Coronary Artery

Locations shown

Kurashiki Central Hospital

Kurashiki

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 2, 2013Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions